Back

High-dose vs standard-dose influenza vaccine in older adults with atrial fibrillation, a prespecified analysis of the FLUNITY-HD study

28 August 2026 (10:15 - 10:40)
Organised by: Logo
Congress Presentation Part of: Arrhythmias and risk prediction: epidemiology, biomarkers, and clinical outcomes Epidemiology, Prognosis, Outcome ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Kaveh Hosseini

Herlev and Gentofte Hospital, Copenhagen (Denmark)

3 More presentations in this session

Presentation thumbnail
QTc prolongation and risk of ventricular arrhythmia during amiodarone treatment: a nationwide Danish cohort study
Doctor M. El-Chouli (Roskilde, DK)
Abstract Slides Video
Presentation thumbnail
Successful improvement of ventricular arrhythmic burden after discontinuation of stimulant supplements in structurally normal young patients
Doctor C. Falco (Mogi Mirim, BR)
Abstract Slides Video
Presentation thumbnail
ICM monitoring intensity and atrial fibrillation detection: insights from U.S. Medicare data
Doctor D. Ko (Boston, US)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmias and risk prediction: epidemiology, biomarkers, and clinical outcomes

The Event

Event poster

ESC Congress 2026

28 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Effect of high-dose vs. standard-dose quadrivalent influenza vaccine on death and hospitalizations in older adults with cardiovascular disease: a prespecified analysis of the DANFLU-1 study
31 August 2024
thumbnail
Congress Presentation
ABC-AF study - a randomised controlled study of personalised treatment to reduce stroke or death in atrial fibrillation
30 August 2025
thumbnail
Congress Presentation
Use of antiarrhythmic drugs in elderly patients with nonvalvular atrial fibrillation: analysis of the italian multicenter START registry.
29 August 2025
thumbnail
Congress Presentation
Excess morbidity and mortality associated with seasonal influenza in patients with atrial fibrillation
29 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources